Study population
breast, colorectal, or prostate cancer
ONCOLOGY, DISEASE
Patients recruited in this study were survivors of newly diagnosed or recurrent Stages I‐III breast, colorectal, or prostate cancer who were being treated at one of the two sites: (1) an urban, academic tertiary medical center with multiple oncology programs based on disease site and (2) a rural, regional community medical center with a single general oncology practice. Patients across the three arms of the overall study (mailed SCP or SCP delivered in the context of 1 or 2 visits) received an SCP within 6 months of treatment completion. Study SCP templates were adapted from the American Society of Clinical Oncology templates,